
Process Performance as a Means of Quality Management
March 2, 2022 9:22 pm Leave your thoughtsMarch 2, 2022 Dr. Ammar Khawam, Senior Managing Scientist of Development Solutions at Parsolex, recently had a research article published... View Article
March 2, 2022 Dr. Ammar Khawam, Senior Managing Scientist of Development Solutions at Parsolex, recently had a research article published... View Article
INDUSTRY UPDATE | Press release December 22, 2020 West Lafayette, IN – Parsolex in partnership with Syntegon held a virtual... View Article
On the occasion of Parsolex’s completed capital investment program to enhance our analytical, development and CGMP manufacturing capabilities, the Parsolex team, in collaboration with our strategic partner Syntegon (formerly Bosch Packaging Technologies), is hosting a technical forum of case studies to review how the latest processing technologies are addressing today’s development and manufacturing challenges and an overview of our recently expanded capabilities.
Parsolex was registered to exhibit at the CPhI North America Conference being held September 9-11, 2020, in Philadelphia, PA. Unfortunately, the live event has been canceled due to the global COVID-19 pandemic.
Parsolex was registered to exhibit at the American Association of Pharmaceutical Scientists ("AAPS") 2020 PharmSci 360 international conference on October 25-28, 2020, in New Orleans, LA. Unfortunately, the live event has been canceled due to the global COVID-19 pandemic.
Dear Clients, Partners, and Suppliers: First, we, at Parolex hope that you and your family, friends, and colleagues are safe and healthy. Second, we want to thank you for continued support, confidence, and partnership.
Parsolex’s recent capital investment program and expansion of manufacturing capabilities has been featured in the March 2020 issue of Tablets & Capsules magazine.
Parsolex remains open for business and continues to monitor COVID-19 (coronavirus) pandemic.
Background A global, large-scale pharmaceutical manufacturer had produced for many years a legacy drug product that cured a highly contagious... View Article
Background A major, generic pharmaceutical company developed a formulation for a drug product used to treat high cholesterol levels and... View Article